KALV
KalVista Pharmaceuticals, Inc. Common Stock
$19.46
2.86%
+0.55
Notify me if price changes either direction
Buy KALV stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.0B
Enterprise value
961.3M
Trailing PE
-5.3143633090384
Forward PE
15.66626
PEG Ratio
-4.8360706112249
Enterprise to EBITDA
-5.833
Enterprise to revenue
13.058
Price to book MRQ
62.160069256897
Price to sales TTM
13.498462
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
73.6M
EBITDA
-164816992
Diluted EPS TTM
-3.94
Total Cash (MRQ)
300.2M
Current ratio (MRQ)
5.582
Operating Cash Flow (TTM)
-122431504
KALV trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
